Internetiühendust pole — kuvatakse lehe salvestatud versioon.

Merck KGaA ADR

USUSD
← Aktsiafiltri juurde
US:MRKLSE:0QAHMI:1MRKXMX:MRKVI:MRKXETRA:6MKLSE:0O14US:MKGAFXETRA:MRK

Merck KGaA ADR (LSE:0QAH) — Biotechnology: Pharmaceutical Preparations. Börside arv, kus ettevõtte aktsiatega kaubeldakse: 6. Sellel lehel — hind ja graafik, dividendid, suurimad aktsionärid ja aktsiate arvu ajalugu.

⚠ Ära sega neid: on olemas teine ettevõte sama või väga sarnase nimega. See on eraldi kirje — vaata tickerit, vahetust ja registreerimisnumbrit.
  • Merck KGaA — MRK · XETRA DE Registreerimisnumber teadmata

Ettevõtte kohta

Veebileht
merck.com
Sektor
Health Care · Biotechnology: Pharmaceutical Preparations
Peakontor
RAHWAY, Germany
Tegevjuht
Kai Beckmann
Töötajad
62 136
Ringluses olevad aktsiad
2.47 mld seisuga 2026-07-31
Vabalt kaubeldavad aktsiad
644.35 mln
Turukapitalisatsioon
67.93 mld USD
Siseringi isikud
0%
Institutsionaalsed investorid
0.02%
Tegevusala (SIC)
Pharmaceutical Preparations
Õiguslik vorm
XSNP
ISIN
US58933Y1055
LEI
4YV9Y5M8S0BRK1RP0397
Väljamaksesuhe
262%
FCF
16.1 mld USD
52%
Võlg
51.1 mld USD
2.8 a FCF
Dividendistaaž
56+ a
Kasum, FCF ja dividendid makstud — 12 kuu jooksul kuni 30.06.2026 (ettevõtte viimane raport).
Kirjeldus

Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.

Börsid ja tikkerid

BörsTikkerValuutaHindTüüp
US USA StocksMRK lisanoteeringUSD142.38 -0.29%tavalised aktsiad
LSE London Stock Exchange0QAH IOBUSD148.65 -0.12%tavalised aktsiad
MI Borsa Italiana (Milan)1MRKX põhinoteeringEUR129.56 +3.96%tavalised aktsiad
MX Mexican Stock ExchangeMRK lisanoteeringMXN2 690 +6.68%tavalised aktsiad
VI Vienna Stock ExchangeMRK lisanoteeringEUR124.84 -2.79%tavalised aktsiad
XETRA Xetra6MK lisanoteeringEUR129.78 +0.09%tavalised aktsiad

Hind 3 kuu jooksul

3M1Y3Y5Y
tõususepäev langusepäev dividendi ex-kuupäev väljamakse kuupäevViige kursor / puudutage päeva — avamis-, sulgemis-, kõrgeim ja madalaim hind

Dividendid

Viimased 12 kuud, LSE:0QAH: 3.4 USD (4 väljam.)

Merck KGaA ADR (0QAH) maksab dividende kvartalis. Viimase 12 kuu jooksul maksti 3.4 USD aktsia kohta (maksed: 4). See on umbes 2.29% praegusest aktsiahinnast. Makseajaloo põhjal oodatakse järgmist ex-dividendi kuupäeva umbes 15.12.2026. Katkematu dividendiajalugu: 56 aastat.

Ex-kuupäevVäljamakseSumma%TüüpTikker
2026-09-152026-10-070.8500 USD0.6/2.3 %kord kvartalisLSE:0QAH
2026-06-152026-07-080.8500 USD0.6/2.3 %kord kvartalisLSE:0QAH
2026-03-162026-04-070.8500 USD0.6/2.2 %kord kvartalisLSE:0QAH
2025-12-152026-01-080.8500 USD0.6/2.2 %kord kvartalisLSE:0QAH
2025-09-152025-10-070.8100 USD0.5/2.2 %kord kvartalisLSE:0QAH
2025-06-162025-07-080.8100 USD0.5/2.2 %kord kvartalisLSE:0QAH
2025-03-172025-04-070.8100 USD0.5/2.1 %kord kvartalisLSE:0QAH
2024-12-16—0.8100 USD0.5/2.1 %kord kvartalisLSE:0QAH
2024-09-16—0.7700 USD0.5/2.1 %kord kvartalisLSE:0QAH
2024-06-17—0.7700 USD0.5/2.0 %kord kvartalisLSE:0QAH
2024-03-14—0.7700 USD0.5/2.0 %kord kvartalisLSE:0QAH
2023-12-14—0.7700 USD0.5/2.0 %kord kvartalisLSE:0QAH
2023-09-14—0.7300 USD0.5/2.0 %kord kvartalisLSE:0QAH
2023-06-14—0.7300 USD0.5/1.9 %kord kvartalisLSE:0QAH
2023-03-14—0.7300 USD0.5/1.9 %kord kvartalisLSE:0QAH
2022-12-14—0.7300 USD0.5/1.9 %kord kvartalisLSE:0QAH
2022-09-14—0.6900 USD0.5/1.9 %kord kvartalisLSE:0QAH
2022-06-14—0.6900 USD0.5/1.4 %kord kvartalisLSE:0QAH
2022-03-14—0.6900 USD0.5/0.9 %kord kvartalisLSE:0QAH
2021-12-14—0.6900 USD0.5/0.5 %kord kvartalisLSE:0QAH

Selle nädala uudised

Ettevõtte veebisaidilt uudiseid veel pole.

reklaam

Suurimad omanikud

OmanikOsalusAktsiadAruande kuupäev
BlackRock9.2%227 mln2026-06-30
Vanguard Capital Managem…6.54%161.32 mln2026-06-30
State Street Corporation4.88%120.41 mln2026-06-30
Wellington Management Gr…3.5%86.25 mln2026-06-30
VANGUARD INDEX FUNDS-Van…3.18%78.41 mln2026-06-30
Vanguard Portfolio Manag…2.75%67.74 mln2026-06-30
VANGUARD INDEX FUNDS-Van…2.59%64 mln2026-06-30
Geode Capital Management…2.46%60.74 mln2026-06-30
Charles Schwab Investmen…2.2%54.37 mln2026-06-30
Morgan Stanley1.97%48.64 mln2026-06-30
FMR, LLC1.84%45.44 mln2026-06-30
JPMORGAN CHASE & CO1.78%43.89 mln2026-06-30
iShares Trust-iShares Co…1.33%32.89 mln2026-08-31
Fidelity Concord Street…1.29%31.94 mln2026-07-31
SCHWAB STRATEGIC TRUST-S…1.25%30.86 mln2026-05-31
SPDR S&P 500 ETF TRUST-S…1.22%30.22 mln2026-08-31
VANGUARD INDEX FUNDS-Van…0.95%23.51 mln2026-06-30
SELECT SECTOR SPDR TRT-S…0.72%17.75 mln2026-08-31
VANGUARD SPECIALIZED FUN…0.65%15.95 mln2026-07-31
VANGUARD SPECIALIZED FUN…0.57%13.97 mln2026-07-31
DAVIS ROBERT M (Chief Ex…≈0.02%450 3512026-04-29
CHATTOPADHYAY SANAT (Off…≈0.01%200 6752026-04-29
DELUCA RICHARD ROBERT JR…≈0%110 1672026-08-12
LI DEAN Y (Officer)≈0%94 4312026-04-29
LITCHFIELD CAROLINE (Chi…≈0%92 3002026-04-29
ZACHARY JENNIFER L (Gene…≈0%45 5092026-08-12
GUINDO CHIRFI (Officer)≈0%36 6132026-08-13
WILLIAMS DAVID MICHAEL (…≈0%31 7162026-08-05
ROMANELLI JOSEPH EDWARD…≈0%28 7392026-01-26
OOSTHUIZEN JOHANNES JACO…≈0%21 8952026-04-29
Trust for Professional M…0%24 8032026-05-31
Rhumbline Advisers0%10 9192026-06-30
SP Funds Trust-SP Funds…0%6 5422026-07-31
Atlas Capital Advisors I…0%2 4672026-06-30
Gamma Investing LLC0%2 3022026-06-30
Salomon & Ludwin, LLC0%3562026-06-30
PNC Financial Services G…0%22026-06-30
The Vanguard Group———